Rivus Pharmaceuticals

aid: rivus-pharmaceuticals
name: Rivus Pharmaceuticals
description: 'Rivus Pharmaceuticals is a privately held clinical-stage biopharmaceutical company founded in 2019, with corporate
  offices in South San Francisco, California and research operations in Charlottesville, Virginia. Grounded in mitochondrial
  biology, it develops oral small-molecule controlled metabolic accelerators for obesity and associated cardio-metabolic disease.
  Lead candidate HU6 is in Phase 2 development for metabolic dysfunction-associated steatohepatitis (MASH) and has reported
  Phase 2a data in obesity-related heart failure with preserved ejection fraction (HFpEF); RV-8451, an oral non-peptide GLP-1
  receptor agonist for obesity, is in IND-enabling studies. Rivus is a therapeutics developer, not a software or technology
  vendor: it publishes no developer program, public API, SDK or machine-readable specification of any kind.'
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://www.rivuspharma.com/themes/default/images/logo.svg
url: https://raw.githubusercontent.com/api-evangelist/rivus-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Healthcare
- Drug Development
- Metabolic Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rivus-pharmaceuticals-domain-security.yml
- type: Website
  url: https://www.rivuspharma.com/
- type: About
  url: https://www.rivuspharma.com/about/
- type: News
  url: https://www.rivuspharma.com/news/
- type: Careers
  url: https://www.rivuspharma.com/careers/
- type: PrivacyPolicy
  url: https://www.rivuspharma.com/privacy/
- type: TermsOfService
  url: https://www.rivuspharma.com/terms/
- type: LinkedIn
  url: https://www.linkedin.com/company/rivus-pharmaceuticals
- type: SecondaryMarket
  url: https://forgeglobal.com/rivus-pharmaceuticals_stock/
- type: WellKnown
  url: well-known/rivus-pharmaceuticals-well-known.yml
- type: LLMsTxt
  url: llms/rivus-pharmaceuticals-llms.txt
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Rivus Pharmaceuticals is a clinical-stage biopharmaceutical company whose product is a drug (HU6) rather than software
    — the public site carries only About, Focus, Pipeline, News and Careers, no api./developer./docs./portal./app./status.
    host resolves for rivuspharma.com, no Rivus GitHub organisation exists under any plausible name, and every spec-discovery
    and /.well-known/ path returns a genuine 404 on both the apex and www hosts (the site root returns 200 and a deliberate
    control path also returns 404, so these are real absences, not a soft-404 catch-all).
  evidence:
  - url: https://www.rivuspharma.com/openapi.json
    status: 404
  - url: https://www.rivuspharma.com/.well-known/agent-card.json
    status: 404
  - url: https://www.rivuspharma.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/rivuspharma
    status: 404
  - url: https://www.rivuspharma.com/
    status: 200
  checked: '2026-08-05'